Skip to main content
Toggle menu
Home
donanemab
donanemab
An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly
Wed, 05/03/2023 - 06:00
Tech Insider
A brain scan.
BSIP/Universal Images Group via Getty Images
Healthcare
,
Biotech
,
Drug Development
,
Eli Lilly
,
Alzheimer's Disease
,
Dispensed
,
donanemab
Subscribe to donanemab
sfy39587stp18